Explore the Global Lung Cancer Molecular Biomarker Market— analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.

Future Market Insights

Lung Cancer Molecular Biomarker Market

Key Insight

The lung cancer molecular biomarker market is projected to grow from USD 6.2 billion in 2026 to USD 17.3 billion by 2036, at a CAGR of 10.8%. EGFR will dominate with a 28.0% market share, while therapy selection will lead the application segment with a 48.0% share.

January 13, 2026

Anurag Sharma

250 Pages

Cite this Report

Lung Cancer Molecular Biomarker Market

https://www.futuremarketinsights.com/reports/lung-cancer-molecular-biomarker-market

License

Starting at US$ 5000

Buy Now

Summary ToC Infographics Companies

Key Players

Agilent Technologies
Illumina
Qiagen
Hoffmann-La Roche
Thermo Fisher Scientific Inc.

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Lung Cancer Molecular Biomarker Market

Key Players

Similar Industry Reports